Neurophysiological trajectories in Alzheimer's disease progression

被引:4
|
作者
Kudo, Kiwamu [1 ,2 ]
Ranasinghe, Kamalini G. [3 ]
Morise, Hirofumi [1 ,2 ]
Syed, Faatimah [3 ]
Sekihara, Kensuke [4 ]
Rankin, Katherine P. [3 ]
Miller, Bruce L. [3 ]
Kramer, Joel H. [3 ]
Rabinovici, Gil D. [3 ,5 ]
Vossel, Keith [3 ,6 ]
Kirsch, Heidi E. [1 ]
Nagarajan, Srikantan S. [1 ]
机构
[1] Univ Calif San Francisco, Biomagnet Imaging Lab, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA
[2] Ricoh Co Ltd, Med Imaging Business Ctr, Kanazawa, Japan
[3] Univ Calif San Francisco, UCSF Weill Inst Neurosci, Memory & Aging Ctr, San Francisco, CA USA
[4] Signal Anal Inc, Hachioji, Japan
[5] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA USA
[6] Univ Calif Los Angeles, Mary S Easton Ctr Alzheimers Res & Care, David Geffen Sch Med, Dept Neurol, Los Angeles, CA USA
来源
ELIFE | 2024年 / 12卷
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; magnetoencephalography; biomarkers; electrophysiology; functional connectivity; Human; MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; FUNCTIONAL CONNECTIVITY; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; AMYLOID-BETA; SYNAPSE LOSS; MODEL; RECOMMENDATIONS;
D O I
10.7554/eLife.91044
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Forecasting individual progression trajectories in Alzheimer's disease
    Maheux, Etienne
    Koval, Igor
    Ortholand, Juliette
    Birkenbihl, Colin
    Archetti, Damiano
    Bouteloup, Vincent
    Epelbaum, Stephane
    Dufouil, Carole
    Hofmann-Apitius, Martin
    Durrleman, Stanley
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Forecasting individual progression trajectories in Alzheimer’s disease
    Etienne Maheux
    Igor Koval
    Juliette Ortholand
    Colin Birkenbihl
    Damiano Archetti
    Vincent Bouteloup
    Stéphane Epelbaum
    Carole Dufouil
    Martin Hofmann-Apitius
    Stanley Durrleman
    Nature Communications, 14
  • [3] Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease
    Smailovic, Una
    Kareholt, Ingemar
    Koenig, Thomas
    Ashton, Nicholas J.
    Winblad, Bengt
    Hoglund, Kina
    Nilsson, Per
    Zetterberg, Henrik
    Blennow, Kaj
    Jelic, Vesna
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (01) : 355 - 366
  • [4] Predicting clinical progression trajectories of early Alzheimer's disease patients
    Devanarayan, Viswanath
    Ye, Yuanqing
    Charil, Arnaud
    Andreozzi, Erica
    Sachdev, Pallavi
    Llano, Daniel A.
    Tian, Lu
    Zhu, Liang
    Hampel, Harald
    Kramer, Lynn
    Dhadda, Shobha
    Irizarry, Michael
    ALZHEIMERS & DEMENTIA, 2024, 20 (03) : 1725 - 1738
  • [5] Neurophysiological Changes in Alzheimer's Disease
    Nurten, Asiye
    ACTA PHYSIOLOGICA, 2018, 225 : 10 - 10
  • [6] Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer's disease progression: a systematic review
    Costanzo, Matteo
    Cutrona, Carolina
    Leodori, Giorgio
    Malimpensa, Leonardo
    D'antonio, Fabrizia
    Conte, Antonella
    Belvisi, Daniele
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [7] Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression
    Tok, Sean
    Ahnaou, Abdallah
    Drinkenburg, Wilhelmus
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 88 (03) : 809 - 836
  • [8] Bradykinesia in Alzheimer's disease and its neurophysiological substrates
    Bologna, Matteo
    Guerra, Andrea
    Colella, Donato
    Cioffi, Ettore
    Paparella, Giulia
    Di Vita, Antonella
    D'Antonio, Fabrizia
    Trebbastoni, Alessandro
    Berardelli, Alfredo
    CLINICAL NEUROPHYSIOLOGY, 2020, 131 (04) : 850 - 858
  • [9] Assessing disease progression in Alzheimer's disease
    Katzourou, I.
    Holmans, P.
    Williams, J.
    Escott-Price, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 31 : S61 - S62
  • [10] Trajectories of cognitive decline in Alzheimer's disease
    Wilkosz, Patricia A.
    Seltman, Howard J.
    Devlin, Bernie
    Weamer, Elise A.
    Lopez, Oscar L.
    DeKosky, Steven T.
    Sweet, Robert A.
    INTERNATIONAL PSYCHOGERIATRICS, 2010, 22 (02) : 281 - 290